Clinical Trials : I will be talking with my... - PBC Foundation

PBC Foundation

9,484 members8,376 posts

Clinical Trials

gwillistexas profile image
16 Replies

I will be talking with my hepatologist next Friday about a clinical trial he will be conducting. All I know is the drug is from France. He says he is very encouraged with their results so far. I have a few questions for him, but I’m hoping some of you who have been in trials might help me with a few questions to ask. I know I would have to be off Ocaliva for 3 months. Not too keen about being without my drug that long. Any help will be appreciated.

Thanks

Gail

Written by
gwillistexas profile image
gwillistexas
To view profiles and participate in discussions please or .
Read more about...
16 Replies
Candy12 profile image
Candy12

A trial for GENFIT,: Elafibranor, is in trials in Europe and the US, for PBC so perhaps it’s that one.

Maybe have a read of : clinicaltrials.gov/ct2/show...

It may help prompt questions. I guess if it were me and I was given the placebo, I’d want to know if there would come a point when I’d be put back on medication, if there were any worsening of my bloods from being off OCA. Hope all goes well.

gwillistexas profile image
gwillistexas in reply toCandy12

Thank you. I will definitely read up on it. Have a great day!

PBCCarol profile image
PBCCarol in reply toCandy12

I think they are in the phase without placebo

gwillistexas profile image
gwillistexas in reply toPBCCarol

Oh that would be nice. Are you familiar with the drug?

butterflyEi profile image
butterflyEi

I understand that the drug Rifampicin is not so effective when it is restarted after stopping. I would want to know if Ocaliva has that same effect or if there are any other known side effects for stopping ocaliva and starting again. What if you end up in the placebo group what are the disbenefits to your liver. Having raised the points contarily being part of clinical research is an amazing thing to do for you and the wider community . Let us know how you do.

gwillistexas profile image
gwillistexas in reply tobutterflyEi

Great point. I’m at work so I’ll get back to you later today 😊

gwillistexas profile image
gwillistexas in reply tobutterflyEi

So, I have wondered how being off ocaliva would affect my liver. At this point we’re not sure it is helping me. When he discussed the biopsy results, I asked if he thought it wasn’t working. He said it could be that I am one who progress faster naturally, so it isn’t necessarily ocaliva not working. I feel like I’m in a round room looking for a corner. Ocaliva is my only option for now.

Ktltel profile image
Ktltel

That is exciting news. What are the qualifications to be a part of it?

Stella❤

gwillistexas profile image
gwillistexas in reply toKtltel

I’m not sure. When he first discussed the possibility, it depended on if I met criteria. So maybe I’ll find out Friday. I suppose I meet it.

PBCCarol profile image
PBCCarol

That would be Elfibanor from Genfit

gwillistexas profile image
gwillistexas in reply toPBCCarol

Thank you 😊

gwillistexas profile image
gwillistexas in reply toPBCCarol

And that is the one Candy12 mentioned as well.

gwillistexas profile image
gwillistexas in reply toPBCCarol

I researched it. From all I read, it failed. So I’m hoping it’s not that one. I won’t be involved in that one.

ninjagirlwebb profile image
ninjagirlwebb in reply togwillistexas

It failed in its trials to address NASH, but they are doing new studies for its use for pbc.

biospace.com/article/genfit...

With the failure, elafibranor joins a number of other experimental drugs that have been unable to crack through and achieve regulatory victory in NASH, a metabolic liver disease estimated to affect more than 16 million people in the U.S. alone. Last month, the FDA issued a Complete Response Letter to Intercept Pharmaceuticals for its NASH treatment, obeticholic acid.

GENFIT said the decision to terminate the Phase III study is the first step of a new corporate strategy that includes a renewed focus on developing elafibranor in primary biliary cholangitis (PBC), a chronic, autoimmune disease in which bile ducts in the liver are gradually destroyed. The company called PBC “an exciting opportunity” as the market is expected to reach $1.5 billion by 2035 and remains an area of high, unmet need. Elafibranor showed promising results in a Phase II clinical trial for PBC and was granted Breakthrough Therapy designation by the U.S. Food and Drug Administration for this indication. GENFIT’s clinical team is focused on the launch of a Phase III study.

gwillistexas profile image
gwillistexas in reply toninjagirlwebb

Yes, I did read about that as well last night. I will let you all know after I talk with my hep on Friday. Thank you 😊

gwillistexas profile image
gwillistexas in reply toninjagirlwebb

I did go back and read my article from genfits website. I should have kept reading and I would have seen the positive for PBC. Sounds promising. 🌞

Not what you're looking for?

You may also like...

Drug trials

Hello , been to see my consultant and he said my liver as got worse and that they have a pbc nurse...
janejulie profile image

Trials for new drug in uk

Hi haven't posted in awhile as I have not had much contact with my Dr at all about the condition...
Lilbear89 profile image

Non responder/clinical trial

Hello everyone, 2 issues I'd appreciate help on please. I saw the consultant on Monday who...
Rosie2410 profile image

Liver Biopsy Results today.....

Tonight i learned i have PBC and Autoimmune Hepatitis overlapping each other. Crazy, I know. I've...
SmileSun69 profile image

Clinical trial for Seladelpar

Has anyone had experience with Seladelpar? I have been accepted into a clinical trial and will be...
kat750 profile image

Moderation team

See all
PBCCheryll profile image
PBCCheryllAdministrator
janethomas profile image
janethomasModerator
Cupcake1971_ profile image
Cupcake1971_Moderator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.